144 related articles for article (PubMed ID: 29554340)
1. Mortality causes and trends associated with giant cell arteritis: analysis of the French national death certificate database (1980-2011).
Aouba A; Gonzalez Chiappe S; Eb M; Delmas C; de Boysson H; Bienvenu B; Rey G; Mahr A
Rheumatology (Oxford); 2018 Jun; 57(6):1047-1055. PubMed ID: 29554340
[TBL] [Abstract][Full Text] [Related]
2. Giant-cell arteritis-related mortality in France: A multiple-cause-of-death analysis.
Chazal T; Lhote R; Rey G; Haroche J; Eb M; Amoura Z; Cohen Aubart F
Autoimmun Rev; 2018 Dec; 17(12):1219-1224. PubMed ID: 30316993
[TBL] [Abstract][Full Text] [Related]
3. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis.
Kermani TA; Warrington KJ; Crowson CS; Ytterberg SR; Hunder GG; Gabriel SE; Matteson EL
Ann Rheum Dis; 2013 Dec; 72(12):1989-94. PubMed ID: 23253927
[TBL] [Abstract][Full Text] [Related]
4. Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study.
Ninan J; Nguyen AM; Cole A; Rischmueller M; Dodd T; Roberts-Thomson P; Hill CL
J Rheumatol; 2011 Oct; 38(10):2215-7. PubMed ID: 21844141
[TBL] [Abstract][Full Text] [Related]
5. Survival and death causes of patients with giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Brekke LK; Fevang BS; Diamantopoulos AP; Assmus J; Esperø E; Gjesdal CG
Arthritis Res Ther; 2019 Jun; 21(1):154. PubMed ID: 31238961
[TBL] [Abstract][Full Text] [Related]
6. Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.
Pujades-Rodriguez M; Duyx B; Thomas SL; Stogiannis D; Smeeth L; Hemingway H
Heart; 2016 Mar; 102(5):383-9. PubMed ID: 26786818
[TBL] [Abstract][Full Text] [Related]
7. The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK.
Robson JC; Kiran A; Maskell J; Hutchings A; Arden N; Dasgupta B; Hamilton W; Emin A; Culliford D; Luqmani RA
Ann Rheum Dis; 2015 Jan; 74(1):129-35. PubMed ID: 24095936
[TBL] [Abstract][Full Text] [Related]
8. All-cause and cause-specific mortality in patients with giant cell arteritis: a nationwide, population-based cohort study.
Therkildsen P; Nielsen BD; de Thurah A; Hansen IT; Nørgaard M; Hauge EM
Rheumatology (Oxford); 2022 Mar; 61(3):1195-1203. PubMed ID: 34164660
[TBL] [Abstract][Full Text] [Related]
9. Mortality in patients with giant cell arteritis.
Baslund B; Helleberg M; Faurschou M; Obel N
Rheumatology (Oxford); 2015 Jan; 54(1):139-43. PubMed ID: 25122725
[TBL] [Abstract][Full Text] [Related]
10. Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period.
Catanoso M; Macchioni P; Boiardi L; Muratore F; Restuccia G; Cavazza A; Pipitone N; Mancuso P; Luberto F; Salvarani C
Arthritis Care Res (Hoboken); 2017 Mar; 69(3):430-438. PubMed ID: 27214746
[TBL] [Abstract][Full Text] [Related]
11. Incidence of giant cell arteritis in six districts of Paris, France (2015-2017).
Gonzalez Chiappe S; Lechtman S; Maldini CS; Mekinian A; Papo T; Sené T; Mahr AD
Rheumatol Int; 2022 Oct; 42(10):1721-1728. PubMed ID: 35819504
[TBL] [Abstract][Full Text] [Related]
12. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.
Li L; Neogi T; Jick S
Rheumatology (Oxford); 2017 May; 56(5):753-762. PubMed ID: 28077689
[TBL] [Abstract][Full Text] [Related]
13. Incidence Trends and Mortality of Giant Cell Arteritis in Southern Norway.
Andersen JB; Myklebust G; Haugeberg G; Pripp AH; Diamantopoulos AP
Arthritis Care Res (Hoboken); 2021 Mar; 73(3):409-414. PubMed ID: 31909871
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and management of giant cell arteritis in France: a study based on national health insurance claims data.
Mahr A; Belhassen M; Paccalin M; Devauchelle-Pensec V; Nolin M; Gandon S; Idier I; Hachulla E
Rheumatology (Oxford); 2020 Jan; 59(1):120-128. PubMed ID: 31382293
[TBL] [Abstract][Full Text] [Related]
15. Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
Semin Arthritis Rheum; 2017 Apr; 46(5):650-656. PubMed ID: 27839741
[TBL] [Abstract][Full Text] [Related]
16. Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.
Mohammad AJ; Englund M; Turesson C; Tomasson G; Merkel PA
J Rheumatol; 2017 Jan; 44(1):84-90. PubMed ID: 27803140
[TBL] [Abstract][Full Text] [Related]
17. Causes of death among United States decedents with ALS: An eye toward delaying mortality.
Larson TC; Goutman SA; Davis B; Bove FJ; Thakur N; Mehta P
Ann Clin Transl Neurol; 2023 May; 10(5):757-764. PubMed ID: 37000988
[TBL] [Abstract][Full Text] [Related]
18. Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017.
Kim D; Li AA; Cholankeril G; Kim SH; Ingelsson E; Knowles JW; Harrington RA; Ahmed A
Diabetologia; 2019 Jul; 62(7):1185-1194. PubMed ID: 31011776
[TBL] [Abstract][Full Text] [Related]
19. The burden of diabetes-related mortality in France in 2002: an analysis using both underlying and multiple causes of death.
Romon I; Jougla E; Balkau B; Fagot-Campagna A
Eur J Epidemiol; 2008; 23(5):327-34. PubMed ID: 18386133
[TBL] [Abstract][Full Text] [Related]
20. Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden.
Zöller B; Li X; Sundquist J; Sundquist K
Scand J Rheumatol; 2013; 42(6):487-97. PubMed ID: 23815287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
